Interestingly, while brain-targeted SHP2 gene invalidation translated into severe weight gain, systemic SHP2 inhibition did not worsen the obesity phenotype of the HFD-fed mice, probably because leptin signaling was already blunted [41,42,68,84]. Here, LEP is linked to obesity disorder.